Civil Rights
Movements, leaders, victories and the continuing fight for equality.
q2K BHP
Black History Portal
THE BHP WIRE —
HIDDEN TRUTHS
What's New!
Explore the people, places, events, achievements, struggles and stories that shaped our journey.
Movements, leaders, victories and the continuing fight for equality.
Innovation, patents, science, technology and world-changing contributions.
Pioneers, champions, Negro Leagues, records, activism and excellence.
Meet the people whose lives, choices and achievements shaped the journey.
Black towns, communities, institutions and places where history happened.
Moments that changed communities, movements, institutions and the nation.
Mansa Musa was the ruler of the Mali Empire in West Africa. Details recorded here should be sourced; unknown information is left blank.
MORE →Reflects the personal views, recollections, and perspective of the author, Mike Davis.
This is a personal recollection on the Move fire on May 13, 1985
 | |
| Type | Public |
|---|---|
| Industry | Pharmaceutical (animal) |
| Founded | 1954  |
| Headquarters | Indianapolis, Indiana, U.S. |
| Key people |
|
| Products | Pharmaceutical drugs (animal) |
| Revenue |  US$4.715 billion (2025)[2] |
| US$ 0.901 billion (2025)[2] | |
| US$ 0.473 billion (2025)[2] | |
| Total assets | US$13.358 billion (2025)[2] |
| Total equity | US$10.85 billion (2026)[2] |
Number of employees | 9,450 (2026)[3] |
| Website | elanco |
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.[4]
The company traces its roots back to 1953 when Eli Lilly introduced their first antibiotic aimed at veterinary usage, with the new plant and animal sciences research being combined into Lilly's Agro-industrial division led by George Barnes.[citation needed] In the 1960s, the Agro-Industrial division was reorganised launching Elanco Products, short for the parent company name, Eli Lilly and Company.[5]
In the 1980s, research moved away from plant sciences and focused on animal health and food quality. In the 1990s, another reorganisation led to the company being renamed Elanco Animal Health, focusing solely on animal health.[citation needed]
In 2007, the business acquired Ivy Animal Health and launched its companion animal business. In 2008, Elanco partnered with Heifer International. In 2009, the business launched its data analytics business, Elanco Knowledge Solutions.[citation needed]
In 2010, the business acquired the European rights to a portfolio of Pfizer Animal Health treatments and an Irish manufacturing site.[citation needed] In 2011, Elanco expanded its footprint in Europe, acquiring Janssen Animal Health. In 2012, the business acquired ChemGen Corp.[6] In 2014, the business acquired Lohmann SE and Lohmann Animal Health for an undisclosed sum and Novartis Animal Health for $5.4 billion. In 2016, Elanco expanded its US-based business, acquiring vaccines from Boehringer Ingelheim Vetmedica for $885 million.[citation needed]
In 2013, Elanco made a $100M investment in China Animal Healthcare.[7]
In 2018, Lilly announced plans to separate its Elanco Animal Health unit from the rest of the business via an initial public offering on the New York Stock Exchange, with the stock-ticker ELAN. In 2019, the divestiture was completed and Elanco launched on the New York Stock Exchange. In the same year, the US FDA approved rabacfosadine, a first-in-class treatment for canine lymphoma. The business continued to expand is US-business, acquiring Aratana Therapeutics, and its first-in-class treatment for canine osteoarthritis. Elanco also announced it would acquire the developer of vaccines for bacterial disease prevention in food-animals, Prevtec Microbia, Inc. In the same year, the business announced it would acquire Bayer's animal health business for $7.6 billion.[8][9]
On December 3, 2020, Elanco announced plans to build a new global headquarters in Indianapolis at the site of the former GM stamping plant, which is located across the White River from the downtown area. The business plans to break ground on the new headquarters in the first half of 2021.[10][needs update]
In August 2021, Elanco announced it had closed its acquisition of Kindred Biosciences.[11]
Elanco's flea and tick collar, branded "Seresto", which was developed by Bayer Animal Health and acquired by Elanco in 2020, has been linked to more than 98,000 incidents of poisoning by pesticide, including more than 2,000 pet deaths, according to a 2022 report by a subcommittee of the House Committee on Oversight and Reform. The collars are not registered for sale in Canada.[12][13]
In April 2022, Elanco officially broke ground on its new 40-acre global headquarters in Indianapolis. The campus, located at the former GM stamping plant site, is designed to serve as a central hub for the "Animal Health Clinic" innovation district.[14]
On July 13, 2023, following a multi-year review, the EPA announced that they were unable to determine whether Seresto was the cause of reported animal deaths. The EPA limited the collar's registration to five years instead of the normal fifteen years registration, as other pesticides normally receive. Elanco and the EPA also agreed to develop a program designed to enhance data collection for adverse event reports and continued annual enhanced reporting of Seresto adverse event data.[15]
In February 2024, Elanco announced a strategic shift to focus on its high-value pet health and livestock sustainability initiatives by selling its aquaculture business to Merck Animal Health for approximately $1.3 billion in cash. The divestiture, which included the company's aqua portfolio and related manufacturing sites, was completed later that year.[16]
Elanco's portfolio includes several "blockbuster" products—brands that generate more than $100 million in annual revenue. These core products span both the pet health and farm animal segments.Key blockbuster brands include:
In 2024, Elanco launched what it termed its "next generation" of potential blockbusters, including Zenrelia, a once-daily oral tablet for canine dermatology, and Credelio Quattro, a broad-spectrum parasiticide designed to protect against ticks, fleas, heartworm, and tapeworms. The company also received FDA approval for Bovaer, a methane-reducing feed ingredient for dairy cattle, which is positioned as a cornerstone of its livestock sustainability portfolio.[18]
Elanco operates under a corporate social responsibility framework known as "Healthy Purpose." The initiative outlines several 2030 goals, including a commitment to help farmers reduce their environmental footprint and improving food security for 100 million people in emerging markets. The company has pledged to achieve "Net Zero" operations by 2030.[24]
Source: Wikipedia. Article content is retrieved live through the MediaWiki API.
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.
The Eli Lilly and Company-Elanco Research Award was a scientific award presented annually by the American Society for Microbiology (ASM) and sponsored by the Eli Lilly and Company and its subsidiary Elanco (which became an independent company in 2019). The prize was first awarded in 1936. Recipients were given 5000 US dollars (as of 2011). It honored young scientists under the age of 45. The award's purpose was not to compare the research of the younger scientists to the research of older scientists, but to encourage originality and independent thinking. The award was discontinued after the last award in 2018. Information about the award can no longer be found on the ASM website.
Ractopamine () is an animal feed additive used to promote leanness and increase food conversion efficiency in farmed animals in few countries, banned in most. Pharmacologically, it is a phenol-based TAAR1 agonist and β adrenoreceptor agonist that stimulates β1 and β2 adrenergic receptors. It is most commonly administered to animals for meat production as ractopamine hydrochloride. It is the active ingredient in products marketed in the US as Paylean for swine, Optaflexx for cattle, and Topmax for turkeys. It was developed by Elanco Animal Health, a former division of Eli Lilly and Company. As of 2025, the use of ractopamine "is banned or its use restricted in 168 nations", including the European Union, China and Russia, while it is legal in some other countries, with differing maximum residual limits (MRLs) in meat. Examples include the United States (50 ppb in pork, 30 ppb in beef); Japan, Taiwan and South Korea (10 ppb, in accordance with the Codex Alimentarius Commission); and New Zealand (0.1 ppb). Commercial ractopamine is a mixture of all four possible stereoisomers. It is also a positional isomer of dobutamine, a related drug.
The economy of Indianapolis is centered on the City of Indianapolis and Marion County within the context of the larger Indianapolis metropolitan area. The Indianapolis–Carmel–Anderson, IN MSA, had a gross domestic product (GDP) of $134 billion in 2015. The top five industries were: finance, insurance, real estate, rental, and leasing ($30.7B), manufacturing ($30.1B), professional and business services ($14.3B), educational services, health care, and social assistance ($10.8B), and wholesale trade ($8.1B). Government, if it had been a private industry, would have ranked fifth, generating $10.2 billion. Compared to Indiana as a whole, the Indianapolis metropolitan area has a lower proportion of manufacturing jobs and a higher concentration of jobs in wholesale trade; administrative, support, and waste management; professional, scientific, and technical services; and transportation and warehousing. The city's major exports include pharmaceuticals, motor vehicle parts, medical equipment and supplies, engine and power equipment, and aircraft products and parts. According to the Bureau of Labor Statistics, the region's unemployment rate was 2.8 percent in May 2019. In 2021, the Indianapolis metropolitan area was home to three Fortune 500 companies and six Fortune 1000 companies. The largest public companies based in the area were insurance company Elevance Health, pharmaceutical company Lilly, agrochemical company Corteva, real estate investment trust Simon Property Group, pharmaceutical (animal health) company Elanco, financial services company CNO Financial Group, specialty chemicals company Calumet, Inc., automotive components manufacturer Allison Transmission, and automotive remarketing company OpenLane. Private companies based in the area include financial services company OneAmerica Financial, agricultural cooperative CountryMark, and regional airline Republic Airways Holdings.
Before the 1921 destruction of Tulsa’s Greenwood District, Black residents had created a remarkable center of business and community life. The district included stores, professional offices, entertainment venues and homes owned by Black citizens. Understanding Greenwood means learning what was built—not only what was burned.
MORE →Joe Louis.